JP2007526891A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526891A5
JP2007526891A5 JP2006518502A JP2006518502A JP2007526891A5 JP 2007526891 A5 JP2007526891 A5 JP 2007526891A5 JP 2006518502 A JP2006518502 A JP 2006518502A JP 2006518502 A JP2006518502 A JP 2006518502A JP 2007526891 A5 JP2007526891 A5 JP 2007526891A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
fzd10
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006518502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526891A (ja
JP4691626B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2004/002144 external-priority patent/WO2005004912A1/en
Publication of JP2007526891A publication Critical patent/JP2007526891A/ja
Publication of JP2007526891A5 publication Critical patent/JP2007526891A5/ja
Application granted granted Critical
Publication of JP4691626B2 publication Critical patent/JP4691626B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006518502A 2003-07-11 2004-02-24 滑膜肉腫の治療方法 Expired - Lifetime JP4691626B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48619503P 2003-07-11 2003-07-11
US60/486,195 2003-07-11
PCT/JP2004/002144 WO2005004912A1 (en) 2003-07-11 2004-02-24 Method for treating synovial sarcoma

Publications (3)

Publication Number Publication Date
JP2007526891A JP2007526891A (ja) 2007-09-20
JP2007526891A5 true JP2007526891A5 (https=) 2007-12-06
JP4691626B2 JP4691626B2 (ja) 2011-06-01

Family

ID=34062116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006518502A Expired - Lifetime JP4691626B2 (ja) 2003-07-11 2004-02-24 滑膜肉腫の治療方法

Country Status (5)

Country Link
EP (1) EP1648506B1 (https=)
JP (1) JP4691626B2 (https=)
AT (1) ATE545658T1 (https=)
ES (1) ES2381841T3 (https=)
WO (1) WO2005004912A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803370B2 (en) 2002-08-30 2010-09-28 Oncotherapy Science, Inc. Method for treating synovial sarcoma
US8158385B2 (en) 2002-10-11 2012-04-17 Chugai Seiyaku Kabushiki Kaisha Cell death-inducing agent
KR101360671B1 (ko) 2005-06-10 2014-02-07 추가이 세이야쿠 가부시키가이샤 sc(Fv)2를 함유하는 의약조성물
KR101367544B1 (ko) 2005-06-10 2014-02-26 추가이 세이야쿠 가부시키가이샤 메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
DK2500360T3 (en) 2005-10-31 2015-10-26 Oncomed Pharm Inc Compositions and methods for the diagnosis and treatment of cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
CN101573383B (zh) * 2006-06-21 2015-05-13 肿瘤疗法科学股份有限公司 靶向肿瘤的针对卷曲同源物10的单克隆抗体及其用途
AU2007319360A1 (en) * 2006-11-14 2008-05-22 Novartis Ag Methods of treating, diagnosing or detecting cancer
CL2008000719A1 (es) * 2007-03-12 2008-09-05 Univ Tokushima Chugai Seiyaku Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
CN103002911B (zh) 2008-09-26 2015-08-26 昂考梅德药品有限公司 卷曲蛋白结合药剂及其应用
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt拮抗劑及治療和篩選方法
CA2794674A1 (en) 2010-04-01 2011-10-06 Oncomed Pharmaceuticals, Inc. Frizzled-binding agents and uses thereof
EP2720721B1 (en) 2011-06-17 2017-08-30 President and Fellows of Harvard College Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
EP2742067A4 (en) * 2011-08-12 2015-03-04 Omeros Corp MONOCLONAL FZD10 ANTIBODIES AND METHOD FOR THEIR USE
WO2013157410A1 (ja) * 2012-04-17 2013-10-24 Hoya株式会社 Fzd10結合性ペプチド
WO2014066328A1 (en) 2012-10-23 2014-05-01 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
JP2016510411A (ja) 2013-02-04 2016-04-07 オンコメッド ファーマシューティカルズ インコーポレイテッド Wnt経路インヒビターによる処置の方法およびモニタリング
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
TWI762516B (zh) 2016-10-06 2022-05-01 日商腫瘤療法 科學股份有限公司 針對fzd10之單株抗體及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB9414580D0 (en) * 1994-07-19 1994-09-07 Cancer Res Campaign Tech Materials and methods relating to the diagnosis of synovial sarcomas
US5994098A (en) * 1997-06-02 1999-11-30 Smithkline Beecham Corporation Human 7-TM receptor similar to murine frizzled-6 gene
EP0943684A3 (en) * 1998-03-10 2002-01-23 Smithkline Beecham Plc Frizzled-like polypeptides and polynucleotides
GB9819681D0 (en) * 1998-09-09 1998-11-04 Smithkline Beecham Plc Novel compounds
US6991901B2 (en) * 2001-01-11 2006-01-31 Curagen Corporation Proteins and nucleic acids encoding same
US20030044409A1 (en) * 2001-05-01 2003-03-06 Carson Dennis A. Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens

Similar Documents

Publication Publication Date Title
JP2007526891A5 (https=)
JP2009541204A5 (https=)
JP2005528099A5 (https=)
JP2010516708A5 (https=)
JP2018198596A5 (https=)
JP2007527406A5 (https=)
JP2020526478A5 (https=)
US20100036101A1 (en) Antibodies against non functional p2x7 receptor
JP2011526785A5 (https=)
JP2011528561A5 (https=)
US20150111250A1 (en) Methods and compositions for modulating tumor cell activity
JP2009517057A5 (https=)
CN111278861A (zh) Pd-l1抗体、其抗原结合片段及医药用途
RU2009101788A (ru) Направленные на опухоль моноклональные антитела против fzd10 и их применение
JP2018504105A5 (https=)
RU2014149332A (ru) Антитела против клаудина 18.2 для диагностики рака
RU2009120052A (ru) Композиции и способы связывания сфингозин-1-фосфата
JP2010523096A5 (https=)
RU2010129558A (ru) ЭЛЕМЕНТ, СВЯЗЫВАЮЩИЙСЯ С АЛЬФА-РЕЦЕПТОРОМ ИНТЕРЛЕЙКИНА-4 (IL-4Rα)-173
RU2010136940A (ru) Антитела против альфа5-бета1 и их применение
HRP20130922T1 (hr) U potpunosti humana protutijela protiv humanog 4-1bb (cd137)
JP2015506912A5 (https=)
JP2010501164A5 (https=)
RU2011103199A (ru) Антитела против cdh3, меченные радиоизотопной меткой, и их применение
JP2011526249A5 (https=)